Summary
By means of the multiple marker analysis, a total of 55 human leukemia-lymphoma cell lines which included 15 T-cell, 30 B-cell, four myelomonocytic-cell, and six non-T, non-B cell lines was characterized for their marker profiles. The multiple markers used included a number of cell surface markers as detected by either rosette or immunofluorescence tests, enzyme assays, cytogenetic analysis, and certain functional assay. Based on the criteria previously defined it was found that all the cell lines were proved to represent original leukemia-lymphoma of ALL, AML, CLL, CML in blastic phase or variety of lymphomas. The monoclonality, a “frozen” state at a specific stage of differentiation-maturation, and cytogenetic marker in each leukemia-lymphoma cell line were remarkable common properties and were stable for years of cultivation. Similar, if not identical, general characteristics were observed in the study on 344 cases of uncultured fresh leukemia-lymphomas by the multiple marker analysis. While no single marker specific to any type of tumor was found, the study offers not only a basis for better understanding of the biology of leukemia-lymphoma but also an insight into normal hematopoietic cell differentiation in man.
Similar content being viewed by others
References
Andersson LC, Jokinen M, Gahmberg CG (1979) Induction of erythroid differentiation in the human leukaemia cell line K 562. Nature 278:364–365
Billing R, Rafizadeh B, Drew I, Hartman G, Gale R, Terasaki P (1976) Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera. J Exp Med 144:167–178
Bollum FJ (1979) Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 54:1203–1215
Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci 75:2458–2462
Epstein AL, Kaplan HS (1974) Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas. Cancer 34:1851–1872
Graeves MF (1978) Membrane antigens and enzymatic phenotypes in leukaemia: Correlates of normal haemopoietic differentiation? In: Serrou B, Rosenfeld C (eds) Human lymphocyte differentiation: its application to cancer, INSERM Symposium No, 8. Elsevier/North Holland Biochemical Press, 253–264
Greaves MF, Brown G, Rapson NT, Lister TA (1975) Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol 4:67–84
Greaves M, Janossy G (1978) Patterns of gene expression and the cellular origins of human leukaemias. Biochem Biophys Acta 516:193–230
Greaves MF, Janossy G, Francis G, Minowada J (1978) Membrane phenotypes of human leukemic cells and leukemic cell lines: Clinical correlates and biological implications. In: Clarkson B, Marks PA, Till JE (eds) Differentiation of normal and neoplastic hematopoietic cells. Cold Spring Harbor Laboratory, 823–841
Greaves MF, Janossy G, Roberts M, Rapson NT, Ellis RB, Chessels J, Lister TA, Catovsky D (1977) Membrane phenotyping: Diagnosis, monitoring, and classification of acute “lymphoid” leukaemias. Haematol Bloodtransfus 20:61–74
Janossy G, Goldstone AH, Capellaro D, Greaves MF, Kulenkampff J, Pippard M, Welsh K (1977) Differentiation linked expression of p 28, 33 (Ia-like) structures on human leukaemic cells. Br Haematol 37:391–402
Janossy G, Greaves MF, Revesz T, Lister TA, Roberts M, Durrant J, Kirk B, Catovsky D, Beard MEJ (1976) Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of “lymphoid” and myeloid cases. Br J Haematol 34:179–192
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497
Koshiba H, Minowada J, Pressman D (1978) Rabbit antiserum against a non-T, non-B leukemia cell line which carries the Ph' chromosome (NALM-1): Antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen. J Natl Cancer Inst 61:987–991
Koyama K, Nakamuro K, Tanigaki N, Pressman D (1977) Alloantigens of human lymphoid cell lines; “human Ia-like antigens”. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology 33:217–230
Lok MS, Koshiba H, Han T, Abe S, Minowada J, Sandberg AA (1979) Establishment and characterization of human B-lymphocytic lymphoma cell lines (BALM-3,-4 and-5): Intraclonal variation in the B-cell differentiation stage. Int J Cancer 23:572–578
Metzgar RS, Mohanakumar T (1978) Tumor-associated antigens of human leukemia cells. Seminars in Hematology 15:139–156
Mier JW, Gallo RC (1980) Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA 77:6134–6138
Minowada J (1978) Markers of human leukaemia-lymphoma cell lines reflect haematopoietic cell differentiation. In: Serrou B, Rosenfeld C (eds) Human lymphocyte differentiation: its application to cancer, INSERM Symposium No. 8. North Holland Biomedical Press, 337–344
Minowada J, Janoosy G, Greaves MF, Tsubota T, Srivastava BIS, Morikawa S, Tatsumi E (1978) Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst 60:1269–1277
Minowada J, Ohnuma T, Moore GE (1972) Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 49:891–895
Minowada J, Sagawa K, Lok MS, Kubonishi I, Nakazawa S, Tatsumi E, Ohnuma T, Goldblum N (1980) A model of lymphoid-myeloid cell differentiation based on the study of marker profiles of 50 human leukemia-lymphoma cell lines. Serrou B, Rosenfeld C (eds.). In: International Symposium on new trends in human immunology and cancer immunotherapy. Doin Paris, pp 188–199
Minowada J, Tsubota T, Nakazawa S, Srivastava BIS, Huang CC, Oshimura M, Sonta S, Han T, Sinks LF, Sandberg AA (1977) Establishment and characterization of leukemic T-cell lines, B-cell lines, and null-cell line: a progress report on surface antigen study of fresh lymphatic leukemias in man. Haematol Bloodtransfus 20:241–250
Moore GE (1972) Cultured human lymphocytes. J Surg Oncol 4:320–353
Moore GE, Kitamura H (1968) Cell line derived from patient with myeloma. NY State J Med 68:2054–2060
Nilsson K, Andersson LC, Gahmberg CG, Forsbeck K (1980) Differentiation in vitro of human leukemia and lymphoma cell lines. Serrou B, Rosenfeld C (eds). In: International Symposium on new trends in human immunology and cancer immunotherapy. Doin Paris, pp 271–282
Nilsson K, Pontern J (1975) Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15:321–341
Pulfertaft RJ (1964) Cytology of Burkitt's tumour (African lymphoma). Lancet I:238–240
Reinherz, EL, Schlossman SF (1980) The differentiation and function of human T-lymphocytes. Cell 19:821–827
Sagawa K, Koshiba H, Lok MS, Minowada J (1979) Identification of an antigen associated with granulocyte differentiation in man. Proc. 13th Int. Leukocyte Culture Conf, 109
Schlossman SF, Chess L, Humphreys RE, Strominger JL (1976) Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci 73:1288–1292
Thierfelder S, Rodt H, Thiel E, Hoffmann-Fezer G, Netzel B, Haas RJ, Wundisch GF, Bender-Gotze CH (1979) Immunologic markers for classification of leukemias and non-Hodkin lymphomas. Recent Results in Cancer Res 69:41–48
Tsubota T, Minowada J, Nakazawa S, Sinks LF, Han T, Higby D, Pressman D (1977) Correlation of surface marker of cells of human lymphatic leukemias with disease type. J Natl Cancer Inst 59:845–850
Author information
Authors and Affiliations
Additional information
Supported by USPHS grants CA-14413, CA-17609, CA-25865, AI-08899, and contract 31-CB74165 from the National Cancer Institute and National Institute of Allergy and Infectious Diseases
Rights and permissions
About this article
Cite this article
Minowada, J., Koshiba, H., Sagawa, K. et al. Marker profiles of human leukemia and lymphoma cell lines. J Cancer Res Clin Oncol 101, 91–100 (1981). https://doi.org/10.1007/BF00405069
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00405069